NCT05015504Active, not recruiting
Application of Time Restriction Feeding in Patients With Type 2 Diabetes Mellitus
Source: ClinicalTrials.gov · Last updated 3 Aug 2026
Brief summary (registry, in English)
In this 3-week interventional study, the investigators hypothesize that therapeutic Time-Restricted Feeding in patients with poorly controlled Type 2 diabetes mellitus (T2DM) can improve their mean glucose or estimated glycated hemoglobin levels with the same dose, or even reduced dose, of antidiabetics.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 16 Aug 2021
- Start date
- 10 Feb 2022
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- OhioHealth
- Diseases
- Type 2 diabetes
- NCT number
- NCT05015504
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 10 Feb 2022 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Advanced stage of renal (stage 4 or above) or hepatic (cirrhosis) or respiratory (needs oxygen) or heart failure (NYHA class 3 or above)
- Active infection or malignancy
- Dementia, or other significant mental impairment that would, in the opinion of the investigator, impede patient self-reporting
- Clinician-reported history of patient non-adherence
Lab values
- Severe hypoglycemic episodes (defined as having low blood glucose levels that requires assistance from another person to treat) in the past 12 months
Other
- Pregnant or breastfeeding patients
- Unable to give informed consent
- Currently enrolled in another therapeutic study
- Thyroid dysfunction, as defined by abnormal thyroid function test results within the past 6 months
Who the study is looking for
- Age ≥ 18 years and \< 65 years
- With the diagnosis of type 2 diabetes
- A1c \>= 8.0 on the most recent test in the 3 months before enrollment
- Have been on stable antidiabetics in the 3 months before enrollment
- OhioHealth Patient
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| OhioHealth Castrop Health Center Coordinator of this site? Confirm its status | Athens | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.